Share on StockTwits

Physicians Realty Trust (NYSE:DOC) has been given an average recommendation of “Buy” by the nine analysts that are covering the company, ARN reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $15.46.

DOC has been the subject of a number of recent research reports. Analysts at Compass Point raised their price target on shares of Physicians Realty Trust from $16.00 to $16.50 in a research note on Thursday. Separately, analysts at Oppenheimer raised their price target on shares of Physicians Realty Trust from $14.00 to $15.50 in a research note on Monday, August 11th. They now have an “outperform” rating on the stock. Finally, analysts at MLV & Co
initiated coverage on shares of Physicians Realty Trust in a research note on Friday, June 27th. They set a “buy” rating and a $16.00 price target on the stock.

Physicians Realty Trust (NYSE:DOC) opened at 14.42 on Tuesday. Physicians Realty Trust has a 52-week low of $11.00 and a 52-week high of $14.77. The stock’s 50-day moving average is $14.34 and its 200-day moving average is $13.63. The company’s market cap is $495.2 million.

Physicians Realty Trust (NYSE:DOC) last issued its quarterly earnings data on Wednesday, August 13th. The company reported $0.17 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.23 by $0.06. The company had revenue of $11.40 million for the quarter, compared to the consensus estimate of $10.40 million. Analysts expect that Physicians Realty Trust will post $0.82 EPS for the current fiscal year.

Physicians Realty Trust is a real estate investment trust (NYSE:DOC).

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with Analyst Ratings Network's FREE daily email newsletter.